{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:59:25Z","timestamp":1782572365002,"version":"3.54.5"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The left atrial appendage (LAA) is a major source of thrombus and non-chicken wing (CW). LAA morphology is a risk factor for embolic events in atrial fibrillation. However, the association of non-CW morphology with embolic stroke recurrence is unknown in patients with embolic stroke of undetermined source (ESUS) and atrial cardiopathy.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We conducted retrospective analyses using a prospective institutional stroke registry (2013\u20132017). Patients with ESUS and atrial cardiopathy were enrolled. Atrial cardiopathy was diagnosed if an increased left atrial diameter (&amp;gt;40 mm, men; &amp;gt;38 mm, women), supraventricular tachycardia, or LAA filling defect on computed tomography (CT) were present. Patients admitted &amp;gt;24 h after onset were excluded. LAA morphology was evaluated using CT and categorized into CW vs. non-CW types. The primary outcome was embolic stroke recurrence. Multivariable Cox proportional hazards models were used to examine the independent association between LAA morphology and outcome.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of 157 patients, 81 (51.6%) had CW LAA morphology. The median follow-up was 41.5 (interquartile range 12.3\u201358.5) months corresponding to 509.8 patient years. In total, 18 participants experienced embolic stroke recurrences (3.80 per 100 patient-years). Non-CW morphology was more associated with embolic stroke recurrence than CW morphology (hazard ratio (HR), 3.17; 95% confidence interval (CI), 1.13\u20138.91; <jats:italic>p<\/jats:italic> = 0.029). After adjusting for CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score and number of potential embolic sources, non-CW morphology showed an independent association with outcome (adjusted HR, 2.90; 95% CI, 1.02\u20138.23; <jats:italic>p<\/jats:italic> = 0.045).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The LAA morphology types may help identify high risk of embolic stroke recurrence in ESUS with atrial cardiopathy. LAA morphology in atrial cardiopathy may provide clues for developing therapies tailored to specific mechanisms.<\/jats:p>","DOI":"10.3389\/fneur.2021.679320","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T05:25:26Z","timestamp":1624339526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of Left Atrial Appendage Morphology on Recurrence in Embolic Stroke of Undetermined Source and Atrial Cardiopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Dong-Seok","family":"Gwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WooChan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: a review","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1161\/STROKEAHA.114.006364","article-title":"P-wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis","volume":"45","author":"Kamel","year":"2014","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.115.016795","article-title":"Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate","volume":"132","author":"Goldberger","year":"2015","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jacc.2015.04.069","article-title":"Premature atrial contractions: a wolf in sheep's clothing?","volume":"66","author":"Marcus","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.jacc.2015.03.557","article-title":"Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences","volume":"65","author":"Hirsh","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke: time for a new model","volume":"47","author":"Kamel","year":"2016","journal-title":"Strok"},{"key":"B10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/STROKEAHA.117.020059","article-title":"Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study)","volume":"49","author":"Kamel","year":"2018","journal-title":"Stroke"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e013227","DOI":"10.1161\/JAHA.119.013227","article-title":"Atrial cardiopathy in the absence of atrial fibrillation increases risk of ischemic stroke, incident atrial fibrillation, and mortality and improves stroke risk prediction","volume":"9","author":"Edwards","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamaneurol.2019.0617","article-title":"Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial","volume":"76","author":"Healey","year":"2019","journal-title":"JAMA Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1161\/STROKEAHA.112.675942","article-title":"Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy","volume":"44","author":"Longstreth","year":"2013","journal-title":"Stroke"},{"key":"B14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? results from a multicenter study","volume":"60","author":"Di Biase","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1540-8167.2010.01814.x","article-title":"Left atrial appendage studied by computed tomography to help planning for appendage closure device placement","volume":"21","author":"Wang","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.hrthm.2013.01.036","article-title":"Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores","volume":"10","author":"Kimura","year":"2013","journal-title":"Heart Rhythm"},{"key":"B17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jce.12710","article-title":"Why is left atrial appendage morphology related to strokes? an analysis of the flow velocity and orifice size of the left atrial appendage","volume":"26","author":"Lee","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/14779072.2017.1355238","article-title":"Atrial cardiopathy: a mechanism of cryptogenic stroke","volume":"15","author":"Yaghi","year":"2017","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/STROKEAHA.119.028669","article-title":"Potential embolic sources and outcomes in embolic stroke of undetermined source in the NAVIGATE-ESUS Trial","volume":"51","author":"Ntaios","year":"2020","journal-title":"Stroke"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e012858","DOI":"10.1161\/JAHA.119.012858","article-title":"Prevalence and overlap of potential embolic sources in patients with embolic stroke of undetermined source","volume":"8","author":"Ntaios","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1747493016681019","article-title":"Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design","volume":"12","author":"Geisler","year":"2017","journal-title":"Int J Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10554-016-0973-2","article-title":"Double-contrast, single-phase computed tomography angiography for ruling out left atrial appendage thrombus prior to atrial fibrillation ablation","volume":"33","author":"Teunissen","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1161\/STROKEAHA.116.013713","article-title":"Risk stratification for recurrence and mortality in embolic stroke of undetermined source","volume":"47","author":"Ntaios","year":"2016","journal-title":"Stroke"},{"key":"B25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMcp051145","article-title":"Clinical practice: supraventricular tachycardia","volume":"354","author":"Delacretaz","year":"2006","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0735-1097(85)80476-9","article-title":"Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance","volume":"6","author":"Beppu","year":"1985","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCIMAGING.113.001317","article-title":"Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation","volume":"7","author":"Yamamoto","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/ehjci\/jev117","article-title":"Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation","volume":"17","author":"Fukushima","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/STROKEAHA.114.004712","article-title":"N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort","volume":"45","author":"Cushman","year":"2014","journal-title":"Stroke"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.679320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T05:25:28Z","timestamp":1624339528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.679320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":32,"alternative-id":["10.3389\/fneur.2021.679320"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.679320","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"article-number":"679320"}}